Carol Shields
Carol Shields is Chief of the Ocular Oncology Service at Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University in Philadelphia, USA
False
Advertisement
Large Language Models: Is The Hype Real?
April 11, 2024
Assessing the advantages and disadvantages of LLMs
3 min read
The Power of Stick-to-itness
March 29, 2021
If women help each other on the way to the top, there are no limits to what they can achieve
1 min read
Continuing Education
May 5, 2021
Passing knowledge and good practices to new generations of ophthalmologists is vital – it gives teachers a real sense of achievement and, crucially, improves patient care
1 min read
The Ocular Tumor Tsunami
September 16, 2021
What more can be done to avoid devastating waves of advanced eye cancers?
1 min read
Cancer Never Stops – and Neither Do We
September 21, 2020
Organizing our ocular oncology service in unprecedented circumstances
1 min read
A Job for Life
September 19, 2018
Sitting Down With… Carol Shields, Chief of the Ocular Oncology Service at Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University, Philadelphia, PA, USA.
1 min read
The Uniqueness of Uveal Melanoma
May 16, 2014
Uveal and skin melanoma originate in the same type of cell, but are very different in terms of molecular mechanism, pathobiology, prognosis and therapeutic strategy. Here, the features of uveal melanoma are described and the latest therapeutic developments discussed.
1 min read
Newsletters
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.
False
Advertisement